Part of strategic plan to focus on solid dose and parenteral development and manufacturing
Patheon has sold its global secondary clinical packaging and clinical distribution services business to Bellwyck Packaging Solutions, a private company with 20 years’ experience providing clinical trial and contract services for secondary packaging.
‘We are very happy to have reached an agreement with Bellwyck for this business,’ said James C. Mullen, Patheon's Chief Executive Officer. ‘This transaction is part of our continued focus on our core competencies of solid-dose and parenteral development and manufacturing.’
Patheon's secondary clinical packaging and clinical distribution services business is globally managed from its Burlington, Ontario, Canada facility, and includes an operating presence in Cincinnati, Ohio. Terms of the sale have not been disclosed.